Our Diabetes Track will look at the evolution of diabetes care, particularly how medical technology has improved the management and monitoring of the condition. From the advent of CGM’s to the impact of GLP-1’s on the medical device industry, this track will discuss not only how technology is treating diabetes but the potential to reverse the root causes of the disease.

We’ll begin with a focus on technology that enables the measurement of disease. In our second session, we’ll discuss interventions that treat the progression of the disease including surgical solutions. During our last panel, we’ll discuss how medical technology can improve the ongoing maintenance of the disease, as well as proactively reduce complications.

1. Measurement Tech

1:00 – 1:45 PM

Holly Scott, Moderator
Vice President and a Senior Partner, The Mullings Group

Jon Bloom, MD
CEO, Podimetrics

Yael Glassman
Vice President of Business Development and Strategy, Diabetes, Medtronic

Jeff Valk   
CEO, Admetsys

2. Interventional Tech

2:00 – 3:00 PM

Chris Wells, PhD, Moderator
Principal, Consulting, Clarivate

Jay Caplan
Co-Founder and President, Fractyl

Stacey Pugh
CEO, Endogenex

Joe Virgillo
CEO, Morphic Medical

3. Management Tech

3:15 – 4:00 PM

Caroline Irungu, Moderator
Global Commercial Strategy – MedTech, Dassault Systemes

Henrik Bengtsson, EMBA
Senior Innovation Manager, Nova Nordisk

Jessica Lavoie
Head of US Marketing, Healthy.io

Trang Ly, MBBS, FRACP, PhD
Senior Vice President and Medical Director, Insulet